Founded by a group of physicians, CERC has a wide experience in clinical research. Their renown and expertise in this field have enabled them to generate optimal interaction with their industrial partners and other medical research teams focusing on the development of innovative techniques, concepts and treatments.
They provide unparalleled guidance and expert support in a broad range of clinical trials dedicated to the assessment of interventional coronary and peripheral revascularisation, structural and valvular heart disease treatments and adjunctive pharmacology.
Its objectives are to underpin European clinical trials and academic leadership, act as a global CRO and support young scientific leaders.
The CERC’s industrial partners attach great importance to finding cost-effective models which do not compromise quality.
Learn more: www.cerc-europe.org
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
March 31, 2026
Applied Clinical Trials Online Clinical trials are growing more complex, and this trend will increase. Sponsors now expect seamless data capture from electronic systems, labs, wearables, patient-reported outcomes, and third-party sources, all feeding pivotal datasets. As data sources become more diverse and voluminous, the risk of integration and process errors rises. Small oversights in data […]
March 31, 2026
Medtech Dive FDA exempts more wearable, AI features from oversight In a pair of guidance documents, the regulator clarified the types of wellness features and clinical decision support tools that don’t fall under medical device oversight. By: Elise Reuter • Published Jan. 8, 2026 The Food and Drug Administration released two final guidance documents that would […]
February 26, 2026
During the EUCROF 2026 gala dinner in Amsterdam, in front of 300+ participants from the European clinical research ecosystem, the xShare project Open Call Awards for Clinical Research were officially presented. We are extremely proud that Telemedicine Technologies contributed to three complementary xShare Open Call projects (out of 10), all recognised for their quality, innovation […]